Displaying 1 - 14 of 14
| Active Ingredient | PHENYLEPHRINE |
| Therapeutic Class | ALPHA ADRENERGIC AGONIST |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ADRENALINE |
| Therapeutic Class | ALPHA & BETA ADRENERGIC AGONIST |
| Indications | Acute bronchospasm. Emergency treatment of asthma and anaphylaxis, cardiac arrest. |
| Caution | Cardiac arrhythmias, tachycardia, tremor, anxiety . Avoid in the elderly and patients with heart disease. |
| Dose Range | 0.5-1mg s.c. or i.m. |
| Drug Interactions | |
| Pregnancy | May reduce placental perfusion and cause tachycardia, cardiac irregularities, an More ... |
| Breast Feeding | Present in milk but unlikely to be harmful as poor oral bioavailability. |
| Active Ingredient | EPHEDRINE HYDROCHLORIDE |
| Therapeutic Class | ALPHA & BETA ADRENERGIC AGONIST |
| Indications | Reversal of hypotension from spinal or epidural anaesthesia |
| Caution |
Anginal pain; anxiety; arrhythmias; flushing; headache; hypersalivation. |
| Dose Range | 3-6 mg every 3-4 minutes (max. p er dose 9 mg), adjusted according to response, injection solution to contain ephedrine hydrochloride 3 mg/ml; maximum 30 mg p er course. |
| Drug Interactions | |
| Pregnancy | Increased fetal heart rate has been reported. Use with caution during pregnancy. |
| Breast Feeding |
| Active Ingredient | NORADRENALINE |
| Therapeutic Class | ALPHA & BETA ADRENERGIC AGONIST |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | PSEUDOEPHEDRINE |
| Therapeutic Class | ALPHA & BETA ADRENERGIC AGONIST |
| Indications | Symptomatic relief of nasal congestion. |
| Caution | Tachycardia, anxiety, restlessness, and insomnia. |
| Dose Range | Adults and children over 12 years: 60mg every 4-6 hours to a maximum of 4 doses in 24 hours; patients with renal dysfunction should have dose adjustments. Pediatric: 6-12 years: 30mg 3-4 times daily. |
| Drug Interactions | |
| Pregnancy | Pseudoephedrine should be avoided during pregnancy because of the severity of th More ... |
| Breast Feeding | May suppress lactation; avoid if lactation is not well established or if milk pr More ... |
| Active Ingredient | TAMSULOSIN MR |
| Therapeutic Class | SELECTIVE ALPHA 1 ADRENERGIC BLOCKING AGENTS |
| Indications | Benign prostatic hyperlasia. |
| Caution | Abnormal ejaculation, dizziness, arthalgia, headache, nausea, diarrhoea, rhinitis and slight reductions in hemoglobin have been reported. Food may decrease absorption of tamsulosin. Alterations in blo More ... |
| Dose Range | The recommended oral dose for the treatment of benign prostatic hyperplasia is 0.4mg once daily,to be taken ½ hour after same meal daily. See BDS supply protocols pg. 11. |
| Drug Interactions | |
| Pregnancy | Use of tamsulosin is not approved for women. |
| Breast Feeding | Use of tamsulosin is not approved for women. |
| Active Ingredient | METHYLDOPA |
| Therapeutic Class | CENTRAL ALPHA ANTAGONIST |
| Indications | Hypertension. |
| Caution | Rarely : Positive response to direct Coombs tests. Haemolytic anaemia, leukopenia, thrombocytopenia, hepatitis, gynaecomastia and lactation. Safe in asthmatics and pregnancy.Dose dependen More ... |
| Dose Range |
Adult: Initial dose: 250mg 2-3 times daily for 2 days, adjusted every 2 days to a maximum of 3g daily. Maintenance dose: 500mg-2g in 2- 4 divided doses. Pediatric: 10mg/kg in 2-4 divided doses initially , to a maximum of 65mg/kg or 3g whichever is less. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | PRAZOSIN |
| Therapeutic Class | ALPHA ADRENERGIC BLOCKING AGENTS |
| Indications | Benign Prostatic Hypertrophy . |
| Caution |
To reduce incidence of syncope on first dose patient should be given 1mg at bedtime for firstfew doses. Dry mouth, drowsiness and nasal congestion. Dizziness, headache, lack of energy, weakness, palpi More ... |
| Dose Range | Initially 500mcg twice daily for 3-7 days, subsequently adjusting accordingly to response. Maximum dose 2 mg twice daily. |
| Drug Interactions | |
| Pregnancy | Manufacturer advises use only when potential benefit outweighs risk. |
| Breast Feeding | Use prazosin with caution in lactating women as it is distributed in breastmilk. |
| Active Ingredient | TERAZOSIN |
| Therapeutic Class | ALPHA ADRENERGIC BLOCKING AGENTS |
| Indications | Benign prostatic hyperplasia. |
| Caution | Dizziness, lethargy, edema, headache and fatigue.THE FIRST DOSE MUST BE TAKEN AT BEDTIME. Patient should be warned to lie down if symptoms such as dizziness, fatigue or sweating develop, and to rem More ... |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | Manufacturer advises use only when potential benefit outweighs risk. |
| Breast Feeding |
| Active Ingredient | BRIMONIDINE |
| Therapeutic Class | EENT ALPHA ADRENERGIC AGONISTS |
| Indications | Ocular hypotension and glaucoma. |
| Caution | Blurring. lid retraction, headache, fatigue, drowsiness. TO BE USED ONLY IN THOS E PATIENTS UNRESPONS IVE TO OTHER PREPARATIONS . |
| Dose Range | 1 drop 3 times daily. See BDS supply protocols pg. 11. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ACARBOSE |
| Therapeutic Class | ALPHA GLUCOSIDASE INHIBITORS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DUTASTERIDE |
| Therapeutic Class | 5 ALPHA REDUCTASE INHIBITORS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DUTASTERIDE | TAMSULOSIN |
| Therapeutic Class | 5 ALPHA REDUCTASE INHIBITORS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | FINASTERIDE |
| Therapeutic Class | 5 ALPHA REDUCTASE INHIBITORS |
| Indications | Benign prostatic hyperplasia. |
| Caution |
Women/children should not handle tablets. Neoplasm of breast, breast tenderness and swelling, ejaculation disorders erectile dy sfunction, rash, urticaria, depression, testicular pain and decreased More ... |
| Dose Range | 5mg once daily. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |